Revance Therapeutics, Inc. — FDA Facility Profile

FEI 3007772056

Revance Therapeutics, Inc. is an FDA-registered facility (FEI 3007772056) located in Newark, CA, US. Registered operations: ANALYSIS; API MANUFACTURE; MANUFACTURE. RegDataLab tracks 1 FDA inspection at this facility.

Facility Details

Location
Newark, CA (US)
Registration Expires
December 31, 2026
Operations
ANALYSIS; API MANUFACTURE; MANUFACTURE
Source
both